Anthropic Buys a Small Drug Startup as It Pushes Deeper Into Biotech

Anthropic said it acquired Mithril Medicine, a one-person startup developing treatments for two rare forms of muscular dystrophy, a sign of the AI developer’s growing ambitions in drug discovery. The company also said it is working with Bristol Myers Squibb, BigHat Biosciences and four other ...

Also reported by Becker's Hospital Review.

First reported by The Information. This page is a short excerpt; the full text is theirs.